pidemiologic data regarding the incidence and prevalence of inflammatory bowel disease (IBD) among racial groups in the United States are relatively limited. Although emerging literature suggests that the genetic determinants of IBD may differ by race 1 leading to differences in disease presentation, these biological factors may be further modified by disparities in care delivery. Despite the fact that black patients are suspected to have an overall lower prevalence of IBD in the United States, previous studies have suggested that black patients are more likely to experience IBD-related hospitalizations and higher IBD-related mortality when compared with non-Hispanic white and Hispanic populations. 2 In addition, although black race has been associated with an increased likelihood of significant health care expenditures related to IBD, 3 in other evaluations, black patients were less likely to receive therapy with infliximab 4 and thiopurines 5 when compared with white patients. Similarly, Hispanic patients are less likely to receive therapy with biologics and immunomodulators when compared with white patients. 6 In addition to differences in utilization patterns among patients of different races with IBD, racial differences in severity of disease have also been demonstrated. In particular, black patients with IBD have been suggested to have increased rates of perianal disease 7, 8 and upper GI tract Crohn's disease (CD). 7 Differences in disease extent and severity have also been noted between patients of different races with ulcerative colitis (UC), with black patients being more likely to demonstrate proctitis or left-sided colitis when compared with white patients with UC. 4, [9] [10] [11] Among Hispanic patients with IBD in the United States, an increased prevalence of UC has been reported, [12] [13] [14] [15] [16] with foreign-born Hispanic patients demonstrating significantly more UC than US-born Hispanics and non-Hispanic white patients. 6 An evaluation of a large integrated health plan also demonstrated a significant increase in incident cases of UC among Hispanic children over an 11-year period. 17 Most of the literature examining racial differences in the treatment of IBD includes studies that have been conducted in adult populations. However, racial disparities in the treatment of IBD have been suggested in pediatric patients, including increased risk of hospital readmission and longer LOSs among black children with IBD, 18 as well as lower rates of parenteral nutrition. 19 Given these suggestions of differences in both disease presentation and health care resource utilization between white, black, and Hispanic patients with IBD, we used a nationwide inpatient database of pediatric patients to evaluate the presentation and management of children with IBD in the United States. We focused on length of stay (LOS) as a primary outcome while attempting to identify differences in phenotype of disease, hospitalization type, and payer status among patients with IBD of different races.
METHODS

Data Source
We performed a cross-sectional analysis using 2000 to 2012 data from the Kids' Inpatient Database (KID), a nationally representative sample of pediatric hospitalizations from the Healthcare Cost and Utilization Project (HCUP). The KID is the largest publicly available all-payer pediatric inpatient database from the United States that includes data from 15,235,214 hospitalizations from 2000 to 2012. Using data from up to 44 states depending on the year analyzed, the KID is designed to be nationally representative of hospitalization rates and characteristics for all payers and the uninsured. The KID contains over 100 clinical and nonclinical variables, 20 up to 15 International Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-CM) diagnostic and procedure codes, hospital characteristics, and outcomes including hospital LOS, and total charges. Because of the de-identified nature of the data, this study was determined exempt from review by the Institutional Review Board of the University of North Carolina.
Study Sample
We examined discharge data from hospitalizations of patients aged 18 years and younger. Any hospitalization with an ICD-9-CM diagnosis code indicating CD (555.xx) or UC (556.xx) as 1 of the first 3 indications for admission was eligible for inclusion in this study. To minimize misclassification of subgroups of IBD (CD or UC), we excluded hospitalizations with discharge codes for both CD and UC (n ¼ 3187).
Outcome of Interest
The primary outcome of interest, hospital LOS, was determined by evaluating discharge data of individual hospitalizations using data from the KID.
Covariates
During the index admission, multiple covariates associated with a patient's underlying IBD or perceived risk of an increased LOS were evaluated. Patient demographics were analyzed, including age, sex, race, and primary insurance/payer for the index hospitalization. Race was defined using a uniform coding provided by HCUP, where Hispanic patients were uniquely identified as a separate group and not using a Hispanic modifier code. ICD-9-CM diagnosis codes were used to identify additional clinical factors suggested to be independent predictors or confounders of the relationship between IBD and LOS, including the presence of perianal disease among patients with CD, which has been suggested to differ between patients of different races. In addition, we evaluated the presence of fistulizing CD, given our suspicion that CD complicated by a fistula may be associated with increased LOS. For patients with CD, we limited the IBD-related surgery definition to ICD-9-CM coding for abdominal surgeries only (including a previously reported definition for intestinal resection, 21 see Table 1 , Supplemental Digital Content 2, http://links. lww.com/IBD/B643). We excluded perianal procedures. For patients with UC, surgery was defined using previously reported ICD-9-CM coding for colectomy 22 (see Table 1 , Supplemental Digital Content 2, http://links.lww.com/IBD/B643).
Given that comorbidities can also play a significant role in risk for hospitalization and LOS, we included the Charlson comorbidity index in our multivariable analyses. 23 Although not developed for use in pediatric populations, this index has been widely used, including in the evaluation of children. 24, 25 In addition, we adjusted for concomitant infection using a composite outcome created from the most common infections described in previous studies of immunosuppressed patients with IBD and autoimmune disorders. [26] [27] [28] We also evaluated hospital teaching status and IBD-related hospital volume. For the evaluation of IBD-related hospital volume, we used previously identified cutoffs from KID of low-and high-volume centers (#20 admissions annually and .20 admissions annually). 29 However, because of a high correlation between teaching status and IBD-related hospital volume, only hospital teaching status was included in our final models.
Statistical Analysis
All analyses were performed using survey procedures in SAS version 9.4 (SAS Institute, Cary, NC) to account for the complex survey design. These survey procedures also allowed for data to be weighted to reflect estimates of the national population, including the means and proportions presented. We used ChiSquare test and Student's t test to compare proportions and continuous variables, respectively. We separated LOS values into quartiles, and then used logistic regression modeling to estimate the unadjusted odds of a LOS greater than the 75th percentile for the covariates of interest.
Based on clinical knowledge and previously reported risk factors for increased LOS, multivariable logistic regression models were then constructed to evaluate the association between risk factors and a LOS greater than the 75th percentile, adjusting for potential confounders. All factors were included in the model due to their clinical relevance, including payer and hospitalspecific factors, and all factors ultimately included in the final models were identified a priori. Given our suspicion for differential LOSs among surgical and nonsurgical hospitalizations, we also performed secondary analyses where patients who underwent an IBD-related surgery were evaluated separately. A 2-tailed P-value of 0.05 was chosen as the threshold for statistical significance for all tests. Odds ratios (ORs) and 95% confidence intervals (CIs) are presented.
RESULTS
We identified 27,295 hospitalizations of patients with IBD in the 2000 to 2012 KID database (62% CD, 38% UC). Using the KID weighting, these represented 27,034 hospitalizations of patients with CD and 16,247 hospitalizations of patients with UC.
Among hospitalized patients with CD, black patients were more likely to have a diagnosis of perianal disease and were more likely to be discharged from a teaching hospital when compared with white and Hispanic patients (Table 1) . When compared with hospitalized white patients with CD, black and Hispanic patients were less likely to undergo an IBD-related surgery during the admission ( Fig. 1 ) and were more likely to have Medicaid insurance (Table 1) . Among hospitalized patients with UC, similar patterns were demonstrated (Table 2 ), although 59% of black patients with UC were females.
Among all hospitalizations of patients with IBD, the median LOS was 3.59 days (interquartile range [IQR]:1.81-6.51). For patients with CD, the median LOS was 3.39 days (IQR: 1.69-6.11). The median LOS was 3.93 days for patients with UC (IQR: 2.03-7.12). The median LOS for white patients with CD was 3.35 days (IQR: 1.66-5.95). Compared with white patients with CD, the median LOS was longer for black (3.87 days, IQR: 2.01-6.99, P , 0.001) and Hispanic patients with CD (3.72 days, IQR: 1.78-7.10, P , 0.001). The median LOS was significantly longer among Hispanic patients with UC (4.32 days, IQR: 2.23-7.84) when compared with white patients with UC (3.92 days, IQR: 2.06-7.13, P ¼ 0.007). There was no significant difference when comparing the median LOS among black and white patients with UC (3.98 versus 3.92 days, P ¼ 0.186). In both unadjusted analysis and after adjusting for age, perianal disease, fistulizing disease, payer status, admission to a teaching hospital, hospital region, IBD-related surgery, concomitant infection, Charlson comorbidity index score, and year of admission, black patients with CD demonstrated increased odds of a hospital LOS greater than the 75th percentile (adjusted OR [aOR] 1.37, 95% CI:1.22-1.53, P , 0.001) as did Hispanic patients (aOR: 1.37, 95% CI, 1.19-1.59, P , 0.001) when compared with white patients with CD. In addition to minority race, perianal or fistulizing disease, Medicaid insurance, admission to a teaching hospital, and an IBD-related surgery during the admission were all associated with increased LOS (Table 3) . When stratified into surgical and nonsurgical admissions, similar patterns were demonstrated. When compared with hospitalized white patients with CD, black patients with CD demonstrated increased odds of a LOS greater than the 75th percentile in both nonsurgical (aOR: 1.34; 95% CI, 1.18-1.52, P , 0.001) and surgical admissions (1.48; 95% CI, 1.10-2.01, P ¼ 0.012, see Table 2 , Supplemental Digital Content 3, http://links.lww.com/IBD/B644). Hispanic patients with CD also demonstrated an increase in odds of a longer LOS in nonsurgical admissions when compared with white patients with CD (aOR: 1.36; 95% CI, 1.16-1.59, P , 0. 001), although there was no significant difference when evaluating surgical admissions (see Table 2 , Supplemental Digital Content 3, http://links.lww.com/IBD/B644). When evaluating the odds of a LOS greater than the 75th percentile among patients with UC, only Hispanic patients demonstrated a significant increase in odds compared with white patients with UC in both the unadjusted and adjusted analyses (aOR: 1.20; 95% CI, 1.02-1.42, P ¼ 0.015). Other significant predictors of an increased LOS included a colectomy during the admission, discharge from a teaching hospital, and a concomitant infection at the time of admission (Table 4) . When stratifying by whether a colectomy occurred during the admission, Hispanic patients demonstrated an increase in odds of a longer LOS when compared with white patients with UC when limited to nonsurgical hospitalizations (aOR: 1.18; 95% CI, 1.00-1.40, P ¼ 0.029). However, there were no significant differences in LOS among patients of different races when evaluating hospitalizations where a surgery occurred (see Table 3 , Supplemental Digital Content 4, http://links.lww.com/IBD/B645).
DISCUSSION
In a nationally representative sample of pediatric patients with IBD, we demonstrated a significant increase in LOS among hospitalized black and Hispanic patients with CD when compared with hospitalized white patients with CD. In addition, Hispanic patients with UC demonstrated a significantly increased LOS when compared with white patients with UC. We also demonstrated lower rates of IBD-related surgery among hospitalized black and Hispanic patients with IBD when compared with hospitalized white patients with IBD. Black patients and Hispanic patients with IBD were more likely to use Medicaid insurance when compared with white patients with IBD, and black patients were more likely to be discharged from a teaching hospital. When we evaluated LOS for IBD by teaching hospital status alone, those patients admitted to teaching hospitals demonstrated significantly increased LOSs as well.
Our demonstration of an increased LOS among 2 minority populations with IBD is similar to a previous evaluation using the Pediatric Health Information System (PHIS) that demonstrated an increased LOS among black children with CD. 18 In their study, Dotson, et al 18 found that black children had increased frequency of perianal disease, anemia, and vitamin D deficiency, in addition to an increased LOS and re-admissions after index hospitalization. Although we could not evaluate the risk of readmission within KID, we did demonstrate an increased LOS among black patients with CD and among Hispanic patients with both UC and CD using a database that is more nationally representative than the PHIS database, where most of the 44 included centers are tertiary care centers. In addition, the inclusion of Hispanic patients in our analyses would seem to indicate that these potential disparities are not limited to the black population of pediatric patients with IBD and extend to other minority groups.
Although the potential inequalities in the management of IBD among patients of different races has been recognized for some time, 30 the data investigating potential racial disparities among pediatric patients with IBD has been relatively limited. In addition to the study using the PHIS database, 18 Dotson et al used the ImproveCareNow network to demonstrate increased disease severity among black pediatric patients with IBD as compared to white patients. 31 Other previous studies have been limited to single center reports, 32 with smaller sample sizes or have evaluated socioeconomic and demographic factors other than race that may lead to health care disparities, 33, 34 including hospital and Emergency Department resource utilization.
In our analyses, both black and Hispanic pediatric patients with IBD were less likely to have an IBD-related surgery during an inpatient hospitalization when compared with white patients with IBD, even after adjusting for confounders. In a previous evaluation, there was no significant difference in abdominal surgeries or colectomy among black and white pediatric patients with IBD, despite a significant increase in perianal procedures and endoscopies. 18 In a separate study using data from a prospective multi-center registry collected at 26 sites, the rate of surgery among pediatric patients with IBD did not differ by race. 35 In 1 study of adults with IBD from a university medical center, Hispanic patients with UC were less likely to get a colectomy when compared with white patients, whereas there was no difference in colectomy rates when comparing black and white patients with UC. 15 Given that we demonstrated a significant difference in the use of surgery in the management of IBD in our analyses, we also stratified our population by surgical or nonsurgical admissions to evaluate our primary outcome of LOS.
We should also consider the differences in LOS among patients with IBD of different racial groups in comparison to patients with other chronic conditions. When LOS has been evaluated among patients with asthma and Medicaid insurance, LOS was similar among hospitalized black and white children from 33 states. 36 However, in an evaluation of children with systemic lupus erythematosus using the PHIS, Hispanic children demonstrated a median LOS that was 1 day longer than nonHispanic patients. 37 In another evaluation of pediatric patients with chronic comorbidities and Medicaid insurance, black patients undergoing surgery were more likely to demonstrate increased LOS as compared to white patients. 38 The magnitude of the difference in LOS is also critical to consider, given the use of a large, nationwide database in this analysis. Although the median LOSs were significantly longer among black and Hispanic patients with CD as compared to white patients with CD, there is a concern that differences of ,0.5 days may not be clinically meaningful. In studies of other pediatric diseases such as bronchiolitis, differences in LOS of less than 1 day have been reported as clinically important given their association with decreased costs. 39 In addition, when comparing those patients who demonstrated the longest LOSs (those above the 75th percentile), there seem to be more clinically meaningful differences among patients of different races, particularly among hospitalizations of patients with CD.
The role that socioeconomic factors play in outcomes of IBD must not be ignored, given that socioeconomic differences are likely intertwined with apparent differences in approaches to treatment and outcomes among patients of different races. Minority populations such as black and Hispanic patients seem to be overrepresented among Medicaid and uninsured populations when evaluating nationwide trends of adults with IBD. 40 In our evaluation, we demonstrated that black and Hispanic patients were much more likely to have Medicaid insurance when compared with white patients with IBD. In addition, patients with Medicaid were more likely to demonstrate longer LOSs during admissions of patients with both CD and UC. The role that Medicaid insurance plays in outcomes and resource utilization among patients with IBD has been evaluated in previous studies. Both Medicaid insurance and minority race have previously been associated with decreased odds of undergoing small bowel resection for CD. 41 In an evaluation of patients with UC, black patients demonstrated a longer wait time to colectomy during hospitalization, whereas patients with Medicaid demonstrated a significant increase in mortality when undergoing colectomy. 42 Given these results among adults with IBD, we must consider the effects that Medicaid insurance has on outcomes among pediatric patients with IBD.
In addition to the specific issues associated with Medicaid insurance, there are other non-IBD related factors that could influence LOS among black and Hispanic patients. Although we adjusted for comorbidities and coexisting infection during the hospitalization, there are other variables that exist which likely influence LOS that cannot be measured. For example, providerrelated factors including delays in the initiation of appropriate therapy could also influence LOS. In addition, patient preferences regarding interventions such as surgery could also lead to increased LOS, however, these would not be appropriately captured in an administrative database. Delays in the discharge process related to arranging appropriate follow-up, outpatient medications and therapy, and even transportation could all influence LOS, although these may not be directly related to the severity of an individual's IBD. Each of these scenarios could lead to differences in LOS among patients of different racial groups and would require further evaluation in future studies to investigate the potential drivers of disparities in LOS among children with IBD.
Although concomitant infection during an admission with CD or UC seemed to increase an individual's risk for prolonged LOS, a patient's age and the Charlson comorbidity score were not significant predictors of an increased LOS. Among patients with CD, all other regions of the country demonstrated a slight decrease in odds of prolonged LOS when compared with the West. This was also true when evaluating patients with UC, although the comparison between the Northeast and West was not significant.
An important strength of our study was the use of a nationally representative sample of pediatric patients with IBD to evaluate disease behavior (such as perianal disease and fistulizing disease), treatments including utilization of surgery, and resource utilization patterns including hospital LOS. Our study has limitations that should also be noted. Despite demonstrating significant differences in hospital LOS and IBD-related surgery among pediatric patients with IBD of different racial groups, we were unable to fully evaluate disease severity as the KID lacks data on clinical symptoms, laboratory results, and other test findings. To mitigate this, we analyzed the effects of more aggressive phenotypes of CD, perianal disease, and fistulizing CD. 43, 44 Both were associated with increased odds of prolonged LOS. However, the validity of ICD-9 codes for CD-specific phenotypes has not been established in the KID database. In evaluations of administrative databases of adults, a single ICD-10 code has been accurate in the identification of patients with UC and CD. 45 In addition, the KID database allows for cross-sectional analyses only, and thus we were unable to evaluate or account for the potential that a single patient could be admitted multiple times during the course of the study period. Our inability to evaluate readmissions is a significant limitation, particularly given that those patients with the longest LOS are likely the same individuals who are most likely to be readmitted within 30 or 90 days of their index hospitalization.
In conclusion, we used a nationally representative sample of pediatric hospitalizations to demonstrate that black and Hispanic patients with IBD have increased LOS when compared with white patients with IBD, despite a lower frequency of IBDrelated surgery for CD and colectomy for UC during inpatient hospitalizations. These potential disparities in care delivery have been suggested in other studies, and given that our analyses used a nationwide sample of both academic and community practice settings, we feel that these findings should be evaluated further to determine what effects these disparities may have on other clinical outcomes among pediatric patients with IBD. Although these disparities may be due to differences in provider/hospital characteristics, socioeconomic differences, or differences in genetic or other biological factors, these warrant further evaluation to potentially improve the care of pediatric patients with CD and UC.
